Replies to post #385866 on Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

But don't tell Pharma Sleuth..........

He has it all figured out.

Tried to tell everyone they failed a few years ago.

Concerta is difficult to manufacture, and there are abuse-resistance issues. FDA may expect any generic to at least be as abuse-deterrent as the brand name comparator. So, there are at least two significant hurdles for any company trying to get approval and market generic Concerta.

[The ELTP King]

Thanks.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172643382

[imanjen13]

Thanks for the 2016 update to make your point. Lot's to unpack as usual.

[The ELTP King]

Could Elite be pursuing another drug on this list besides Vyvanse?

The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
Published: Aug 23, 2023
https://www.biospace.com/article/9-drugs-losing-patents-or-exclusivity-clauses-by-the-end-of-2023/

Thanks.